A detailed history of Panagora Asset Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Panagora Asset Management Inc holds 479,080 shares of JNJ stock, worth $74.3 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
479,080
Previous 792,090 39.52%
Holding current value
$74.3 Million
Previous $116 Million 32.94%
% of portfolio
0.38%
Previous 0.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $45.5 Million - $52.4 Million
-313,010 Reduced 39.52%
479,080 $77.6 Million
Q2 2024

Jul 29, 2024

BUY
$144.38 - $157.78 $92.6 Million - $101 Million
641,124 Added 424.68%
792,090 $116 Million
Q1 2024

May 07, 2024

SELL
$155.22 - $162.74 $7.26 Million - $7.62 Million
-46,801 Reduced 23.66%
150,966 $23.9 Million
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $14.5 Million - $15.8 Million
-99,247 Reduced 33.41%
197,767 $31 Million
Q3 2023

Oct 31, 2023

SELL
$155.75 - $174.48 $34.5 Million - $38.7 Million
-221,815 Reduced 42.75%
297,014 $46.3 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $1.65 Million - $1.77 Million
-10,683 Reduced 2.02%
518,829 $85.9 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $18.1 Million - $21.7 Million
-120,140 Reduced 18.49%
529,512 $82.1 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $29.2 Million - $32.8 Million
-182,273 Reduced 21.91%
649,652 $115 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $18.2 Million - $20.3 Million
-113,031 Reduced 11.96%
831,925 $136 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $7.32 Million - $8.09 Million
-43,519 Reduced 4.4%
944,956 $168 Million
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $18.7 Million - $21.2 Million
117,967 Added 13.55%
988,475 $175 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $12.2 Million - $13.5 Million
-78,060 Reduced 8.23%
870,508 $149 Million
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $18.7 Million - $20.7 Million
115,480 Added 13.86%
948,568 $153 Million
Q2 2021

Aug 11, 2021

SELL
$159.48 - $171.07 $4.1 Million - $4.4 Million
-25,726 Reduced 3.0%
833,088 $137 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $15.5 Million - $17.2 Million
-101,103 Reduced 10.53%
858,814 $141 Million
Q4 2020

Feb 10, 2021

BUY
$137.11 - $157.38 $730,933 - $838,992
5,331 Added 0.56%
959,917 $151 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $1.1 Million - $1.2 Million
7,805 Added 0.82%
954,586 $142 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $2.69 Million - $3.25 Million
-20,875 Reduced 2.16%
946,781 $133 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $33.2 Million - $46 Million
-298,661 Reduced 23.59%
967,656 $127 Million
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $13.1 Million - $15 Million
-102,595 Reduced 7.49%
1,266,317 $185 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $14.9 Million - $16.6 Million
-117,133 Reduced 7.88%
1,368,912 $177 Million
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $1.79 Million - $1.97 Million
-13,659 Reduced 0.91%
1,486,045 $207 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $32.1 Million - $35.6 Million
-254,950 Reduced 14.53%
1,499,704 $210 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $69.9 Million - $84.1 Million
569,016 Added 47.99%
1,754,654 $226 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $3.14 Million - $3.69 Million
25,810 Added 2.23%
1,185,638 $164 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $11.4 Million - $12.6 Million
-95,536 Reduced 7.61%
1,159,828 $141 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $20.1 Million - $23.8 Million
-160,827 Reduced 11.36%
1,255,364 $161 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $23.1 Million - $25.3 Million
-176,299 Reduced 11.07%
1,416,191 $198 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $206 Million - $216 Million
1,592,490
1,592,490 $207 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.